Behling H, Krafft W, Wagner F
Zentralbl Gynakol. 1987;109(1):42-8.
In vitro testing methods to obtain information about the proliferation of the tumour, which we want to treat by chemotherapy, have been vindicated by the biological individuality of ovarian cancer cells. The determination of the incorporation rate of 3H-thymidine in cells of ovarian cancer by scintillation counting may be recommended as a prognostic factor in regard of success of chemotherapy in patients with this disease.
通过闪烁计数法测定卵巢癌细胞中3H-胸腺嘧啶核苷的掺入率，以此获取有关我们想要通过化疗治疗的肿瘤增殖信息的体外测试方法，已因卵巢癌细胞的生物学个体差异而得到验证。就该疾病患者化疗的成功与否而言，测定卵巢癌细胞中3H-胸腺嘧啶核苷的掺入率可作为一种预后因素。
